[go: up one dir, main page]

WO2007144512A3 - Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires - Google Patents

Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires Download PDF

Info

Publication number
WO2007144512A3
WO2007144512A3 PCT/FR2007/000989 FR2007000989W WO2007144512A3 WO 2007144512 A3 WO2007144512 A3 WO 2007144512A3 FR 2007000989 W FR2007000989 W FR 2007000989W WO 2007144512 A3 WO2007144512 A3 WO 2007144512A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
hypertension
fields
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/000989
Other languages
English (en)
Other versions
WO2007144512A2 (fr
Inventor
Alexis Cordi
Laure Haberkorn
Tony Verbeuren
Christine Courchay
Serge Simonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of WO2007144512A2 publication Critical patent/WO2007144512A2/fr
Publication of WO2007144512A3 publication Critical patent/WO2007144512A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composés de formule (I) : dans laquelle : R1 représente un groupement alkanoyle, R2 représente un groupement alkyle substitué par un groupement G, ou R1 et R2 forment ensemble avec l'atome d'azote qui les porte un groupement imidazolyle ou benzimidazolyle, substitués par un groupement G, et G représente un groupement -(CH2)n-A-(CH2)m-(CR4R5)P-(CH2)O-R3 dans lequel n, m, p, o, R4, R5 et A sont tels que définis dans la description, et R3 représente un groupement formule (II) ou formule (III). Comme antagonistes des recepteurs de l'angiotensine et comme donneurs de NO, utiles dans le domaine de l'hypertension et des pathologies cardiovasculaires.
PCT/FR2007/000989 2006-06-15 2007-06-14 Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires Ceased WO2007144512A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0605318 2006-06-15
FR0605318A FR2902428B1 (fr) 2006-06-15 2006-06-15 Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
WO2007144512A2 WO2007144512A2 (fr) 2007-12-21
WO2007144512A3 true WO2007144512A3 (fr) 2008-03-20

Family

ID=37575276

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/000989 Ceased WO2007144512A2 (fr) 2006-06-15 2007-06-14 Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires

Country Status (3)

Country Link
AR (1) AR061377A1 (fr)
FR (1) FR2902428B1 (fr)
WO (1) WO2007144512A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008005484A1 (de) * 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
EP2244575B1 (fr) * 2008-01-24 2013-07-17 Merck Sharp & Dohme Corp. Antagonistes du récepteur de l'angiotensine ii
AU2009210484A1 (en) * 2008-02-08 2009-08-13 Merck Sharp & Dohme Corp. Angiotensin II receptor antagonists
WO2011053519A1 (fr) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diurétiques
CA2787035A1 (fr) 2010-02-12 2011-08-18 Merck Sharp & Dohme Corp. Derives diazeniumdiolate cyclopentyle
US8623846B2 (en) 2010-05-21 2014-01-07 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclohexyl derivatives
EP2632255B1 (fr) * 2010-10-29 2017-06-21 Merck Sharp & Dohme Corp. Dérivés hétérocycliques de diazéniumdiolate
RU2013138391A (ru) * 2011-01-19 2015-02-27 Мерк Шарп Энд Домэ Корп. Производные диазенийдиолата
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
US9272987B2 (en) 2011-05-02 2016-03-01 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclohexyl derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324377A2 (fr) * 1988-01-07 1989-07-19 E.I. Du Pont De Nemours And Company Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids
WO2004062568A2 (fr) * 2003-01-09 2004-07-29 Amersham Health As Agent de contraste

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324377A2 (fr) * 1988-01-07 1989-07-19 E.I. Du Pont De Nemours And Company Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids
WO2004062568A2 (fr) * 2003-01-09 2004-07-29 Amersham Health As Agent de contraste

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARINI, DAVID J. ET AL: "Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives", JOURNAL OF MEDICINAL CHEMISTRY , 34(8), 2525-47 CODEN: JMCMAR; ISSN: 0022-2623, 1991, XP000674205 *

Also Published As

Publication number Publication date
WO2007144512A2 (fr) 2007-12-21
AR061377A1 (es) 2008-08-20
FR2902428A1 (fr) 2007-12-21
FR2902428B1 (fr) 2008-08-15

Similar Documents

Publication Publication Date Title
WO2007144512A3 (fr) Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires
MX2009010552A (es) Antagonistas de receptor de opioide periferico y usos de los mismos.
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
MY151986A (en) Adamantyl diamide derivatives and uses of same
TR201903663T4 (tr) Ari̇loazol-2-i̇l si̇yanoeti̇lamino bi̇leşi̇kleri̇, bunlarin oluşturulmasi yöntemi̇ ve bunlarin kullanilmasi yöntemi̇.
WO2007107828A3 (fr) Dérivés amine
BRPI0913457B8 (pt) Composto e composição farmacêutica
NO20063866L (no) 1,3,5-trisubstituerte 4,5-di hydro-1 H-pyrazolderivater med CB1-antagonistisk aktivitet.
WO2008022286A3 (fr) petits inhibiteurs moléculaires de la kynurénine-3-monooxygénase
WO2009028543A1 (fr) Dérivé de pyrazole substitué
WO2007148185A3 (fr) 3-amino-pyrrolidino-4-lactames substitués
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
WO2009142732A3 (fr) Dérivés pyridazinone substitués comme ligands des récepteurs de l'histamine-3 (h<sb>3</sb>)
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
MY148703A (en) Polycyclic cinnamide derivatives
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
BRPI0923728A2 (pt) "método de preparação de compostos de di-hidroindeno amida, suas composições farmacêuticas contendo esses compostos e uso como inibidor de proteína quinase".
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
WO2010027236A3 (fr) Composé hétérocyclique condensé
WO2008156677A3 (fr) Ligands peptidiques cycliques des récepteurs de la mélanocortine
MX336366B (es) Antagonistas del receptor opioide periferico y usos de los mismos.
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
TN2009000040A1 (en) 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
DOP2010000329A (es) Inhibidores de la renina
WO2008149834A1 (fr) Dérivé de pyrimidodiazépinone

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07803750

Country of ref document: EP

Kind code of ref document: A2